These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 25988844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma.
    Mahdy RA, Al-Mosallamy SM, Al-Aswad MA, Bor'i A, El-Haig WM.
    Eye (Lond); 2016 Jan; 30(1):53-8. PubMed ID: 26427987
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The Combination of PlGF Inhibition and MMC as a Novel Anti-Scarring Strategy for Glaucoma Filtration Surgery.
    Van Bergen T, Jonckx B, Moons L, Feyen JH, Stalmans I.
    Invest Ophthalmol Vis Sci; 2016 Aug 01; 57(10):4347-55. PubMed ID: 27556218
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
    Sengupta S, Venkatesh R, Ravindran RD.
    J Glaucoma; 2012 Sep 01; 21(7):450-9. PubMed ID: 21543993
    [Abstract] [Full Text] [Related]

  • 6. The outcome of initial mitomycin C-augmented trabeculectomy with subconjunctival bevacizumab in the management of secondary glaucoma associated with Fuchs heterochromic iridocyclitis.
    Elgin U, Sen E, Ozdemir K, Ozdal P, Berker N.
    Int Ophthalmol; 2020 Apr 01; 40(4):795-802. PubMed ID: 31792855
    [Abstract] [Full Text] [Related]

  • 7. Short-term Results of Trabeculectomy Using Adjunctive Intracameral Bevacizumab Versus Mitomycin C: A Randomized Controlled Trial.
    Vahedian Z, Mafi M, Fakhraie G, Zarei R, Eslami Y, Ghadimi H, Mohebbi M.
    J Glaucoma; 2017 Sep 01; 26(9):829-834. PubMed ID: 28777224
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery.
    Wong TT, Mead AL, Khaw PT.
    Invest Ophthalmol Vis Sci; 2005 Jun 01; 46(6):2018-22. PubMed ID: 15914618
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. α5β1-Integrin inhibitor (CLT-28643) effective in rabbit trabeculectomy model.
    Schultheiss M, Schnichels S, Konrad EM, Bartz-Schmidt KU, Zahn G, Caldirola P, Fsadni MG, Caram-Lelham N, Spitzer MS.
    Acta Ophthalmol; 2017 Feb 01; 95(1):e1-e9. PubMed ID: 27576860
    [Abstract] [Full Text] [Related]

  • 12. A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis).
    Sherwood MB.
    Trans Am Ophthalmol Soc; 2006 Feb 01; 104():478-92. PubMed ID: 17471357
    [Abstract] [Full Text] [Related]

  • 13. History, presence, and future of mitomycin C in glaucoma filtration surgery.
    Wolters JEJ, van Mechelen RJS, Al Majidi R, Pinchuk L, Webers CAB, Beckers HJM, Gorgels TGMF.
    Curr Opin Ophthalmol; 2021 Mar 01; 32(2):148-159. PubMed ID: 33315724
    [Abstract] [Full Text] [Related]

  • 14. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
    Nilforushan N, Yadgari M, Kish SK, Nassiri N.
    Am J Ophthalmol; 2012 Feb 01; 153(2):352-357.e1. PubMed ID: 21982106
    [Abstract] [Full Text] [Related]

  • 15. Bevacizumab revisited: its use in different mouse models of ocular pathologies.
    Hollanders K, Van Bergen T, Van de Velde S, Sijnave D, Vandewalle E, Moons L, Stalmans I.
    Curr Eye Res; 2015 May 01; 40(6):611-21. PubMed ID: 25117905
    [Abstract] [Full Text] [Related]

  • 16. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA, Shahien EA, Hussein AM.
    J Glaucoma; 2010 Dec 01; 19(9):622-6. PubMed ID: 20179624
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery.
    Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, Dewerchin M, Maudgal PC, Zeyen T, Spileers W, Moons L, Stalmans I.
    Invest Ophthalmol Vis Sci; 2009 Nov 01; 50(11):5217-25. PubMed ID: 19474408
    [Abstract] [Full Text] [Related]

  • 20. Integrin α5β1 Inhibition by CLT-28643 Reduces Postoperative Wound Healing in a Mouse Model of Glaucoma Filtration Surgery.
    Van Bergen T, Zahn G, Caldirola P, Fsadni M, Caram-Lelham N, Vandewalle E, Moons L, Stalmans I.
    Invest Ophthalmol Vis Sci; 2016 Nov 01; 57(14):6428-6439. PubMed ID: 27893886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.